ACT UP is slamming the Food and Drug Administration for granting Gilead Sciences a seven-year market exclusivity of remdesivir — an antiviral drug that has shown promise in the treatment of COVID-19, also known as the novel coronavirus…
ACT UP is still fighting 33 years later…now it’s the coronavirus.